Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07633106Active, not recruiting
Open-label trial of epinephrine (2 arms), sponsored by Dow University of Health Sciences. Primary endpoint: Glycemic Level. Started Feb 2026; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07633106.